What does CUSIP 501147102 represent in this 13F holders report?

CUSIP 501147102 is the security identifier for KRYS - Krystal Biotech, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held KRYS - Krystal Biotech, Inc. - Common Stock in Q1 2019?

56 institutional investors reported KRYS - Krystal Biotech, Inc. - Common Stock for Q1 2019. Use the holders table for investor-level position and value details.

Krystal Biotech, Inc. - Common Stock (KRYS)

CUSIP: 501147102

Q1 2019 13F Holders as of 31 Mar 2019

Type / Class: Equity / Common Stock
Shares outstanding: 29,067,614
Total 13F shares: 6,652,555
Share change: +443,966
Total reported value: $218,869,000
Price per share: $32.90
Number of holders: 56
Value change: +$15,470,940
Number of buys: 35
Number of sells: 21

Quarterly Holders Quick Answers

What is CUSIP 501147102?
CUSIP 501147102 identifies KRYS - Krystal Biotech, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2019
Previous quarter: Q4 2018

Recent filing periods for CUSIP 501147102:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of KRYS - Krystal Biotech, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	4.3%	1,235,400	$25,672,000	—	31 Dec 2018	13F
FRAZIER MANAGEMENT LLC	13F	Company	3%	875,000	$18,183,000	—	31 Dec 2018	13F
BAKER BROS. ADVISORS LP	13F	Company	2.7%	784,674	$16,306,000	—	31 Dec 2018	13F
GREAT POINT PARTNERS LLC	13F	Company	1.7%	492,100	$10,226,000	—	31 Dec 2018	13F
VANGUARD GROUP INC	13F	Company	1.2%	336,765	$6,998,000	—	31 Dec 2018	13F
CITADEL ADVISORS LLC	13F	Company	1.2%	335,029	$6,961,000	—	31 Dec 2018	13F
Redmile Group, LLC	13F	Company	1.1%	325,000	$6,754,000	—	31 Dec 2018	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	1%	303,520	$6,307,000	—	31 Dec 2018	13F
Knoll Capital Management, LLC	13F	Company	1%	300,000	$6,234,000	—	31 Dec 2018	13F
Artal Group S.A.	13F	Company	0.95%	275,000	$5,715,000	—	31 Dec 2018	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	0.6%	174,625	$3,629,000	—	31 Dec 2018	13F
Nicholas Investment Partners, LP	13F	Company	0.45%	130,976	$2,722,000	—	31 Dec 2018	13F
S Squared Technology, LLC	13F	Company	0.25%	73,900	$1,536,000	—	31 Dec 2018	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.21%	60,603	$1,259,000	—	31 Dec 2018	13F
Invesco Ltd.	13F	Company	0.16%	47,113	$979,000	—	31 Dec 2018	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.14%	41,900	$871,000	—	31 Dec 2018	13F
P.A.W. CAPITAL CORP	13F	Company	0.14%	40,000	$831,000	—	31 Dec 2018	13F
BARCLAYS PLC	13F	Company	0.13%	37,389	$777,000	—	31 Dec 2018	13F
ALPS ADVISORS INC	13F	Company	0.11%	33,344	$693,000	—	31 Dec 2018	13F
Informed Momentum Co LLC	13F	Company	0.11%	33,025	$686,000	—	31 Dec 2018	13F
ArrowMark Colorado Holdings LLC	13F	Company	0.1%	28,723	$597,000	—	31 Dec 2018	13F
Bank of New York Mellon Corp	13F	Company	0.08%	24,677	$513,000	—	31 Dec 2018	13F
NORTHERN TRUST CORP	13F	Company	0.08%	21,845	$454,000	—	31 Dec 2018	13F
BLAIR WILLIAM & CO/IL	13F	Company	0.07%	21,780	$453,000	—	31 Dec 2018	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.07%	20,558	$427,000	—	31 Dec 2018	13F
BlackRock Finance, Inc.	13F	Company	0.07%	19,157	$398,000	—	31 Dec 2018	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.06%	18,697	$389,000	—	31 Dec 2018	13F
Laurion Capital Management LP	13F	Company	0.06%	17,170	$357,000	—	31 Dec 2018	13F
RITHOLTZ WEALTH MANAGEMENT	13F	Company	0.05%	14,409	$299,000	—	31 Dec 2018	13F
Endurant Capital Management LP	13F	Company	0.04%	12,500	$260,000	—	31 Dec 2018	13F
MOORE CAPITAL MANAGEMENT, LP	13F	Company	0.04%	12,500	$260,000	—	31 Dec 2018	13F
BB&T SECURITIES, LLC	13F	Company	0.04%	11,000	$228,000	—	31 Dec 2018	13F
CITIGROUP INC	13F	Company	0.04%	10,303	$214,000	—	31 Dec 2018	13F
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	0.03%	10,038	$209,000	—	31 Dec 2018	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.03%	8,930	$185,000	—	31 Dec 2018	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.03%	7,675	$159,000	—	31 Dec 2018	13F
MORGAN STANLEY	13F	Company	0.01%	4,000	$83,000	—	31 Dec 2018	13F
KBC Group NV	13F	Company	0.01%	2,925	$61,000	—	31 Dec 2018	13F
David M. Knott	13F	Individual	0.01%	1,502	$31,000	—	31 Dec 2018	13F
JPMORGAN CHASE & CO	13F	Company	0%	1,213	$25,000	—	31 Dec 2018	13F
Tower Research Capital LLC (TRC)	13F	Company	0%	1,140	$24,000	—	31 Dec 2018	13F
FEDERATED HERMES, INC.	13F	Company	0%	958	$20,000	—	31 Dec 2018	13F
Dorsey Wright & Associates	13F	Company	0%	685	$14,000	—	31 Dec 2018	13F
UBS Group AG	13F	Company	0%	675	$14,000	—	31 Dec 2018	13F
BANK OF AMERICA CORP /DE/	13F	Company	0%	166	$3,000	—	31 Dec 2018	13F

Institutional Holders of Krystal Biotech, Inc. - Common Stock (KRYS) as of Q1 2019

As of 31 Mar 2019, Krystal Biotech, Inc. - Common Stock (KRYS) was held by 56 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,652,555 shares. The largest 10 holders included FMR LLC, FRAZIER MANAGEMENT LLC, BAKER BROS. ADVISORS LP, GREAT POINT PARTNERS LLC, VANGUARD GROUP INC, Redmile Group, LLC, CITADEL ADVISORS LLC, PRICE T ROWE ASSOCIATES INC /MD/, Artal Group S.A., and Knoll Capital Management, LP. This page lists 56 institutional shareholders reporting positions in this security for the Q1 2019 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2019 vs Q4 2018 Across Filers

Q4 2018 holders

Q1 2019 holders

Holder diff

Investor	Q4 2018 Shares	Q1 2019 Shares	Share Diff	Share Chg %	Q4 2018 Value $	Q1 2019 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.